Joshua Trotta

Joshua Trotta is an experienced leader in the biotechnology and health equity sectors, currently serving as Senior Director of Licensing and Commercial Supply at Thermo Fisher Scientific since November 2021. Trotta is also the General Manager for Global Health Equity, Public Health, and Emerging Markets at the same company. Prior to joining Thermo Fisher, Trotta was the Owner and President of Quantigen Biosciences, a Specialty Contract Research Organization acquired by Versiti, focusing on critical research services and method development, particularly in PCR and sequencing technologies. With a robust career at Thermo Fisher Scientific from 2007 to 2022 in various senior roles, including Sr. Director of Business Development, Trotta has demonstrated expertise in market development and innovative solutions in clinical enablement and genetic analysis.